Financings in Brief: HemaCare Corp.
This article was originally published in The Gray Sheet
HemaCare Corp.: Blood products and services firm nets $1.2 mil. from recently completed private placement of 1.2 mil. shares of common stock. "The use of proceeds include enabling the company to maintain listing compliance with the Nasdaq SmallCap Market," the firm states...
You may also be interested in...
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.